Skip to main content

Pictorial essay: MRI evaluation of endometriosis-associated neoplasms


Endometriosis is a frequent pathology mostly affecting women of young age. When typical aspects are present, the diagnosis can easily be made at imaging, especially at MRI. Transformation of benign endometriosis to endometriosis-associated neoplasms is rare. The physiopathology is complex and remains controversial. Endometrioid carcinoma and clear cell carcinoma are the main histological subtypes. Our goal was to review the main imaging characteristics that should point to an ovarian or extra-ovarian endometriosis-related tumor, especially at MRI, as it may be relevant prior to surgical management.

Key points

• Transformation of benign endometriosis to endometriosis-associated neoplasms is rare.

• MRI is useful when displaying endometriosis lesions associated to an ovarian tumor.

• Subtraction imaging should be used in the evaluation of complex endometriomas.


Endometriosis is a condition characterized by the growth of functional ectopic endometrial glands and stroma outside the uterus. It is a frequent and still underestimated disease, affecting about one in ten women in their reproductive years [1] but also older women following menopause [2].

Malignant transformation of endometriosis is deemed extremely rare, with an estimated prevalence of less than 1% [3].

As a tertiary center specialized in gynecological oncology, we encounter cases of endometriosis-associated malignancy on a regular basis. The aim of this pictorial essay is to provide the key features which enable radiologists to raise a suspicion of endometriosis-associated neoplasms at magnetic resonance imaging (MRI).

Endometriosis and associated neoplasms

Endometriosis is a benign disease. Nevertheless, this condition shares some characteristics with malignant neoplasms, such as development of local and distant foci and attachment to or invasion of other tissues, with subsequent damage to the target organs. Furthermore, endometriosis exhibits recurrence, unregulated cell proliferation, and estrogen-dependent growth [4]. Endometriotic epithelial cells have a higher turnover than their stromal counterpart due to cyclic bleeding and have much higher mutation frequencies. Recent studies have shown that endometriosis lesions carry mutations similar to those of cancer cells [5]. Endometriosis-associated neoplasms encounter molecular abnormalities including the activation of the oncogenic KRAS and PI3K pathways and inactivation of tumor suppressor genes [6]. Oxidative stress, chronic inflammation, and hyper endo/exogenous estrogenism also play a key role in carcinogenesis [5, 6].

Concerning the particularities of endometriosis-related cancers, the patients are often younger [6,7,8], diagnosed at an early FIGO stage, the neoplasm is most likely unilateral [8], and the prognosis is better than cancers without associated endometriosis [9, 10].

The two prevalent histological subtypes are endometrioid adenocarcinoma (67% of cases) and clear cell carcinoma (15% of cases) [11]. Other histological subtypes are less common and include serous adenocarcinoma, mucinous tumors, borderline tumors, and sarcoma [12, 13].

The definitive histological diagnosis is established face to concomitant lesions (Additional file 1: Figs. S1 and S2) of benign endometriosis and malignant components [11]. However, this association is not always found.

Apart from malignant transformations of endometriosis lesions, patients with endometriosis are overall more at risk of developing ovarian or extra-ovarian neoplasms, especially endometrial or breast cancer [14].


Ultrasound (US)

Ultrasound is the first-line imaging modality for the detection of endometriosis. An endometrioma is easy to recognize, corresponding to a cyst with low level of internals echoes [15]. US is also effective in assessing the depth of digestive involvement (Additional file 1: Fig. S3). However, it is an operator-dependent modality which requires experienced hands. In case of increasing in size, the presence of irregular solid component, and blood flow in Doppler mode, the operator should suspect a malignant ovarian lesion at US [16, 17] and require further investigations using cross-sectional imaging [18].

Computed tomography (CT)

CT scans are often performed for another indication but may nevertheless identify suspicious ovarian lesions and guide the diagnosis [19]. CT scans can show a papillary projection in a cystic mass or enhancing solid mural nodules [6]. Its main interest consists of evaluating the extension of the disease, especially by detecting lymph node involvement, peritoneal extension, or lung metastases.

Magnetic resonance imaging (MRI)

MRI is an effective but less accessible modality. Not only does it allow the diagnosis of benign ovarian cyst and deep pelvic endometriosis and associated malignancy, but also the appreciation of loco-regional extension of the disease. It is also useful in detecting recurrences after medical or surgical treatment.

The recommended protocol to explore the pelvic endometriosis has been updated in 2017 by the European Society of Urogenital Radiology [20] and includes T2-weighted images in all orthogonal three planes and T1-weighted sequences with and without fat suppression.

Typical ovarian endometrioma displays moderate low signal intensity on T2-weighted images, called the “T2 shading effect” due to repeated intracystic bleeding. The specificity of this sign is > 90% [9]. Homogeneous, high signal intensity is shown on fat-saturated T1-weighted sequences [1].

Extra-ovarian, deep-pelvic endometriosis usually presents as small hemorrhagic foci or retractile fibrous thickening, especially affecting the torus uterinum and uterosacral ligaments (Additional file 1: Fig. S3).

Intravenous injection of gadolinium chelates is not mandatory in the setting of typical endometriosis, but it should be performed in the presence of a solid component within an endometrioma, in order to better characterize the lesion [18, 21]. Thus, for the exploration of a complex ovarian mass, it is recommended to add the following sequences [16, 22]:

  • Diffusion-weighted imaging (DWI) with at least a high b value of 800, in which solid, cellular portions display high signal intensity with associated low signal on the apparent diffusion coefficient (ADC) map.

  • Dynamic contrast-enhanced (DCE) imaging: in cases of malignant lesions, solid components typically enhance according to a type 3-dynamic curve, i.e., higher than that of the normal myometrium.

These features help classify the lesion according to the recently validated Ovarian-Adnexal Reporting Data System Score at MRI (O-RADS MRI), ranging from 1 to 5. An O-RADS 5 lesion with solid nodules, diffusion restriction, and enhancing pattern following a type 3 dynamic curve presents a high risk of malignancy > 90% [21].

Contrast-enhanced dynamic subtraction images are obtained by using a gradient-echo sequence [22] and subtractions between enhanced and unenhanced fat-saturated T1-weighted images. They are helpful for distinguishing the true enhancement of solid nodules that may be hard to depict within the hemorrhagic cystic fluid of endometriomas on T1-weighted sequences [5].

The typical presentation of a unilocular ovarian mass with hypointensity of the cystic components on T2-weighted imaging may help to distinguish endometriosis-associated malignancy from non-endometriosis-associated malignancy [8].

In patients with a history of endometriosis, increasing in size endometrioma or loss of shading on T2-weighted images [6, 11] should raise concern over a potential malignant transformation. The loss of shading on T2 images is thought to be due to fluid secretions by the malignant components, diluting the chronic hemorrhagic content.

Table 1 summarizes the key MRI features of typical endometrioma and suspicion of endometriosis-associated neoplasm.

Table 1 Schematic MRI features of typical endometrioma and suspicion of endometriosis-associated neoplasm

There is no true discriminating feature to differentiate endometrioid adenocarcinoma from clear cell carcinoma or other malignant pathology (Figs. 1, 2, 3, 4, and 5 and Additional file 1: Figs. S4 and S5). Nevertheless, according to some studies, clear cell carcinoma tends to have a larger tumor size and higher ADC values on DWI with infiltrative growth pattern, heterogeneous signal, and associated ascites [23], whereas endometrioid carcinomas have more multifocal or concentric mural nodules and a higher height-to-width ratio [24].

Fig. 1
figure 1

Endometrioid adenocarcinoma within a right ovarian endometrioma in a 43-year-old woman without any medical history. Axial T2-weighted image (a) shows a large ovarian cystic mass with chronic bleeding (asterisk) displaying a “T2-shading” appearance and peripheral wall nodules (arrows). The axial T1-weighted (b) and fat-suppressed T1-weighted (c) images confirm the hemorrhagic cystic content. Enhancement of the nodules is seen on fat-suppressed T1-weighted following gadolinium chelates injection (d). The axial diffusion image (e) shows the high signal intensity regarding neoplastic nodules, with corresponding low intensity on the ADC map (f). Sagittal T2-weighted image (g) shows features of pelvic endometriosis with uterine adenomyoma (arrowheads) and several hemorrhagic foci (arrowhead) with anterior rectal wall involvement (dotted arrow) on axial fat-suppressed T1-weighted image (h)

Fig. 2
figure 2

Ovarian endometrioid adenocarcinoma within an endometrioma in a 39-year-old woman with a known history of endometriosis. Sagittal T2-weighted image (a) shows a left ovarian cystic mass (asterisk) without a T2-shading effect. Axial T2-weighted image (b) shows a mural nodule (arrow) with restricted diffusion on a high b800 value image and corresponding ADC map (c). The axial fat-suppressed T1-weighted image (d) displays a typical right ovarian endometrioma (arrowheads). Axial contrast-enhanced fat-suppressed T1-weighted image (e) shows a light enhancement of the nodule, better displayed on the subtraction sequence (f). Dynamic contrast enhancement analysis of the nodular portion (g, h) demonstrates a type 3 curve (blue curve, located above normal myometrium in the yellow curve), consistent with a malignant etiology

Fig. 3
figure 3

Clear cell carcinoma on right ovarian endometrioma in a 66-year-old woman with a palpable abdominal mass. Axial T2-weighted image (a) shows a mixed cystic (asterisk) of the right ovary containing a large peripheral solid portion (arrow). Hemorrhagic component (arrowhead) corresponding to endometriomas are displayed on axial fat-suppressed T1-weighted image (b). Enhancement of the solid portions is seen on axial contrast-enhanced fat-suppressed T1-weight image (c) and corresponding subtraction image (d). Diffusion-weighted imaging (e, f) shows restricted diffusion of neoplastic portions. Dynamic contrast enhancement analysis (g high b value and h ADC map) shows a type 3 curve regarding the solid portions (orange curve) located above the myometrial reference curve (pink curve), consistent with malignancy

Fig. 4
figure 4

High-grade serous adenocarcinoma within an endometrioma in a 48-year-old woman with a known history of endometriosis. Coronal (a), sagittal (b), and axial (c) T2-weighted images show severe uterine adenomyosis (white arrowheads) and deep endometriosis involving the posterior compartment (dotted arrows). There is a mixed cystic right ovarian mass (asterisk) with intermediate signal intensity on T2 images (shading effect) containing a mural nodule (black arrows). Diffusion-weighted imaging (d high b value and e ADC map) shows a restricted diffusion within the mural nodule. Axial fat-suppressed T1-weighted image (f) shows the typical features of ovarian endometrioma. Heterogeneous enhancement of the nodule is displayed on fat-suppressed contrast-enhanced T1 image (g) and subtraction sequence (h)

Fig. 5
figure 5

Borderline seromucinous tumor within an ovarian endometrioma in a 77-year-old woman with a long-standing history of endometriosis and previous hysterectomy for cervical cancer. Sagittal (a), coronal (b), and axial (c) T2-weighted images show a mixed ovarian mass filled with typical intermediate signal intensity content (*“shading” effect), containing multiple mural solid nodules (arrows). Axial fat-suppressed T1-weighted image (d) shows the homogeneous hemorrhagic fluid classically found within ovarian endometrioma. Heterogeneous enhancement of the nodules is displayed on fat-suppressed contrast-enhanced T1 image (e), better seen on subtraction sequence (f)

Similar to endometriosis, associated cancers may be extra-ovarian (Figs. 6 and 7). The most commonly affected site is the abdominal wall in scarred areas, especially Cesarian scars [25]. In these patients, the abdominal wall involvement is usually isolated, rarely associated to pelvic endometriosis [26].

Fig. 6
figure 6

Clear cell adenocarcinoma of the abdominal wall in a 44-year-old woman with a history of cesarean section. Sagittal T2-weighted sequence (a) shows the scar on the anterior uterine isthmus (black arrowhead). Sagittal (b) and axial T2-weighted (c) images show a multiloculated cystic lesion developed within the anterior abdominal wall (arrows), infiltrating the right rectus abdominis muscle, without obvious diffusion restriction (d). The axial fat-suppressed T1-weighted image shows a small hemorrhagic spot (arrowhead) within the cyst (e). Diffuse enhancement of the cystic cavity wall and internal septae is seen on fat suppressed-enhanced T1 image (f). There was no surgery-associated pelvic endometriosis in this patient.

Fig. 7
figure 7

Endometrioid adenocarcinoma developed on deep pelvic endometriosis in a 58-year-old woman with a history of infertility. Sagittal (a) and axial (b) T2-weighted images show a large heterogeneous mass obliterating the Douglas cul-de-sac composed of solid (white arrows) and cystic (asterisk) portions. Axial fat-suppressed T1-weighted image shows hemorrhagic content within the cystic cavity (c). Diffusion-weighted imaging (d high b value) shows a high signal intensity within the solid portion with corresponding enhancement on axial enhanced fat-suppressed T1 image (e). Axial T2-weighted sequence at a higher level (f) shows the features of deep pelvic endometriosis of the posterior compartment (dotted arrow) and a metastatic nodule of the mesorectum (arrowhead). “Kissing ovaries” containing small-sized endometrioma (arrowheads) are seen on corresponding fat-suppressed T1-weighted image (arrowheads (g)). Restricted diffusion within the mesorectum metastasis is also seen (h)


The main pitfalls at MRI are as follows:

  • Clot dark spot sign: the presence of a well-defined, markedly hypointense foci within an ovarian cyst on T2-weighted images, corresponding to a blood clot. This sign has a high specificity and is useful for differentiating endometriomas from hemorrhagic cysts in which it is usually absent [27] (Fig. 8 and Additional file 1: Fig. S6).

  • Enhanced endocystic nodules [28], including the following:

    1. Polypoid endometriosis (Fig. 9), which affects more commonly post-menopausal women with hormone replacement therapy. Similar to the uterine endometrium, it appears as a hyperintense T2-weighted polypoid nodule with hypointense peripheric rim, contrast enhancement pattern mirroring the enhancement of the uterine endometrium, and classically lack of diffusion restriction [29].

    2. Cystadenofibroma frequently appears as a multiseptated predominantly cystic mass with variable amounts of solid nodular components. The individual locules may contain hemorrhage or protein content which will modify the T1/T2 intensity cystic signal. The solid component typically displays marked T2 hypointensity, with no restriction in diffusion-weighted imaging (also called “dark-dark appearance”) and progressive enhancement with a type I perfusion curve [30].

    3. Decidualized endometriomas appear exclusively in pregnant women. Mural nodules may show high signal intensity on DWI800 due to T2 shine-through effect, but not on higher b values, which can help distinguish decidualized endometriomas from ovarian cancers [31].

  • Ovarian metastases in patients with endometriosis are frequently bilateral. Krukenberg’s tumors are the most common and originate from a primary adenocarcinoma. In order of frequency, the primary tumor site is the stomach, colon-rectum, appendix, pancreaticobiliary tract, contralateral ovary, endometrium (Fig. 10), breast, or lung. Krukenberg’s tumors are classically mixt lesions with solid components displaying low signal on T1- and T2-weighted sequences, diffusion restriction, and enhancement, associated to cystic areas with T2 hyperintensity and no enhancement [32]. Other cancers can also spread to the ovaries, including melanoma or lymphoma. At US, the “lead vessel” sign corresponding to a main peripheral vessel penetrating within the central part of the ovarian mass with a tree-shaped morphology can help to distinguish metastatic from the primary ovarian lesion in which this sign is absent [33].

  • Other ovarian lesions displaying spontaneous high signal intensity T1-weighted: fat-containing lesions (dermoid cysts), protein-mucinous-containing lesions (mucinous epithelial tumor, abscesses, struma ovarii) or hemorrhagic lesions (functional hemorrhagic cyst, ovarian hematoma complicating adnexal torsion) should also be considered as differential diagnoses [34].

  • Desmoid-type fibromatosis is a rare locally aggressive fibroblastic neoplasm and represents the main differential diagnosis of abdominal wall endometriosis in women with a history of cesarean section. The MRI features depend on its composition but the most commonly observed pattern is iso- or high signal intensity on T2 images, with moderate to intense enhancement and typical low-intensity, non-enhancing linear bands corresponding to dense collagenous stroma [35].

Fig. 8
figure 8

Differential diagnosis: right ovarian endometrioma in an 84-year-old woman with a history of breast cancer. Axial T2-weighted image (a) shows a right ovarian mixed lesion containing simple fluid (asterisk) and solid components (arrows). Due to the hemorrhagic filling, potential enhancement of the solid portion is difficult to appreciate between unenhanced (b) and enhanced (c) fat-suppressed T1 images, whereas the subtraction sequence perfectly displays the lack of enhancement of the solid component (d). The patient underwent surgery: pathology analysis confirmed the presence of blood clots within a benign endometrioma

Fig. 9
figure 9

Differential diagnosis: atypical ovarian endometrioma without malignancy in a 50-year-old woman. Sagittal T2-weighted image (a) shows the thickening of the torus uterinum with adhesions to the anterior wall of the recto-sigmoid (dotted arrow). Axial T2-weighted image (b) shows a left ovarian cystic lesion (asterisk) with T2-shading effect and endocystic peripheral thickening and a polypoid nodule (arrows), both exhibiting diffusion restriction (c). Axial fat-suppressed T1-weighted image (d high b value) confirms the typical features of endometrioma. Axial contrast-enhanced fat-suppressed T1-weighted (e) and subtraction sequence (f) demonstrate significant enhancement of the solid portions (arrows). The patient underwent surgery, and the definitive histological result was a simple endometrioma with endocystic endometrium lining in the proliferative phase, without any associated malignancy

Fig. 10
figure 10

Differential diagnosis: endometrial carcinoma with bilateral ovarian metastases in a 57-year-old woman with endometriosis. T2-weighted images in the sagittal (a), coronal (b), and axial (c) plane show a large intra-uterine mass (thick arrows) and bilateral ovarian masses (thin arrows). All lesions display restricted diffusion (d high b value) and enhancement on axial contrast-enhanced fat-suppressed T1-weighted images (e). Small-sized hemorrhagic foci within the ovarian masses are shown on fat-suppressed T1 weighted image (arrowhead in f), corresponding to superficial endometriosis lesions on the ovarian surface. Surgery confirmed a high-grade endometrial carcinoma with ovarian metastases and underlying endometriosis


Pain and infertility are the main endometriosis-related symptoms that may lead to consider medical or surgical treatment [36].

In cases of ovarian or extra-ovarian malignancy, the treatment depends on the stage of the disease and often consists of surgery and/or chemotherapy.

Prior to surgical treatment, it is interesting for the surgeon to know whether or not there is a suspicion of associated pelvic endometriosis, as it may mean the presence of pelvic adhesions, increasing the risk of lesions of adjacent organs.

In cases of lesions limited to the abdominal wall, the first results concerning the feasibility and safety of using percutaneous cryotherapy are encouraging but almost exclusively described in non-neoplastic lesions [37] (Fig. 11).

Fig. 11
figure 11

Treatment of an endometriosis-associated clear-cell carcinoma on abdominal wall caesarian scar in a 47-year-old woman. Abdominal wall ultrasound scan (a) shows an ill-defined mass containing cystic portions within the rectus abdominis muscle and subcutaneous fat (solid arrows). Further exploration by MRI with axial T2-weighted image (b) shows a mixed lesion high signal intensity on diffusion image (c high b value) and enhancement of the septae on axial contrast-enhanced fat-suppressed T1-weighted (d). The patient benefited from a complete surgical excision and pathology showed a clear cell carcinoma developed on underlying endometrioma. Two years later, local recurrence is shown on the axial T2 image and fat-suppressed enhanced T1 image (dotted arrows in e and f). Multidisciplinary decision was a conservative percutaneous cryotherapy treatment. The CT scan (g) shows the cryoprobe placement and ice formation during treatment (arrowheads). Follow-up MRI scan at 3 months (h axial fat-suppressed enhanced subtraction image) shows complete disappearance of the mass


There are no official guidelines regarding the follow-up of endometriosis. The Nice UK National Guideline Alliance recommends outpatient follow-up for women with confirmed endometriosis (with or without examination or pelvic imaging), particularly women who choose not to have surgery, if they have at least one ovarian endometrioma larger than 3 cm, or deep pelvic endometriosis involving bowel, bladder, or ureter [38].

One study analyzed the time interval between diagnosis of endometrial cyst and associated malignancy: most of the cases evolved to cancer within 120 months [39].

Imaging follow-up could be proposed for patients with known endometriosis and should be performed whenever a change in symptoms is noted (Fig. 12).

Fig. 12
figure 12

Malignant evolution of an ovarian endometrioma in a 37-year-old woman. Sagittal (a) and axial (b) T2 images and axial fat-suppressed T1 images (c, d) show the pelvic endometriosis with torus uterinum thickening (dotted arrows) and typical bilateral endometriomas (arrowheads). A simple clinical surveillance was decided. MRI scan (axial and sagittal T2 images (e, f) and axial fat-suppressed T1 images before and after injection of gadolinium chelates (g, h)) performed 6 years later due to a palpable abdominal mass showed a large ovarian mixed lesion with a cystic component (asterisk) and endocystic tumoral nodules (black arrow in f). Surgery was performed and found a left ovarian borderline seromucinous carcinoma developed on endometrioma


Concomitant MRI findings of typical endometriosis lesions and suspicious ovarian tumors should raise concern over a potential malignant transformation of benign endometriosis. Subtraction MR imaging plays a key role in identifying solid components within an endometrioma.

Availability of data and materials

Not applicable.



Apparent diffusion coefficient


Computed tomography


Dynamic contrast-enhanced


Diffusion-weighted imaging


Magnetic resonance imaging




  1. Foti PV, Farina R, Palmucci S et al (2018) Endometriosis: clinical features, MR imaging findings and pathologic correlation. Insights Imaging 9(2):149–72

    Article  PubMed  PubMed Central  Google Scholar 

  2. Cope AG, VanBuren WM, Sheedy SP (2020) Endometriosis in the postmenopausal female: clinical presentation, imaging features, and management. Abdom Radiol (NY) 45(6):1790–9

    Article  PubMed  Google Scholar 

  3. Takeuchi M, Matsuzaki K, Uehara H, Nishitani H (2006) Malignant transformation of pelvic endometriosis: MR imaging findings and pathologic correlation. Radiographics 26(2):407–17

    Article  PubMed  Google Scholar 

  4. Nezhat F, Apostol R, Mahmoud M, el Daouk M (2014) Malignant transformation of endometriosis and its clinical significance. Fertil Steril 102(2):342–4

    Article  PubMed  Google Scholar 

  5. Guo SW (2020) Cancer-associated mutations in endometriosis: shedding light on the pathogenesis and pathophysiology. Hum Reprod Update 26(3):423–49

    Article  PubMed  Google Scholar 

  6. Robinson KA, Menias CO, Chen L et al (2020) Understanding malignant transformation of endometriosis: imaging features with pathologic correlation. Abdom Radiol (NY) 45(6):1762–75

    Article  PubMed  Google Scholar 

  7. Chamié LP, Ribeiro DMFR, Tiferes DA, Macedo Neto AC, de, Serafini PC. (2018) Atypical sites of deeply infiltrative endometriosis: clinical characteristics and imaging findings. Radiographics 38(1):309–28

    Article  PubMed  Google Scholar 

  8. Zhang X, Li M, Tang Z, Li X, Song T (2021) Differentiation between endometriosis-associated ovarian cancers and non-endometriosis-associated ovarian cancers based on magnetic resonance imaging. Br J Radiol 94(1125):20201441

    Article  PubMed  PubMed Central  Google Scholar 

  9. Tran-Harding K, Nair RT, Dawkins A et al (2018) Endometriosis revisited: an imaging review of the usual and unusual manifestations with pathological correlation. Clin Imaging 52:163–71

    Article  PubMed  Google Scholar 

  10. Hermens M, van Altena AM, van der Aa M et al (2021) Ovarian cancer prognosis in women with endometriosis: a retrospective nationwide cohort study of 32,419 women. Am J Obstet Gynecol 224(3):284.e1–284.e10

    Article  PubMed  Google Scholar 

  11. McDermott S, Oei TN, Iyer VR, Lee SI (2012) MR imaging of malignancies arising in endometriomas and extraovarian endometriosis. Radiographics 32(3):845–63

    Article  PubMed  Google Scholar 

  12. Kajiyama H, Suzuki S, Yoshihara M et al (2019) Endometriosis and cancer. Free Radic Biol Med 133:186–92

    Article  CAS  PubMed  Google Scholar 

  13. Matias-Guiu X, Stewart CJR (2018) Endometriosis-associated ovarian neoplasia. Pathology 50(2):190–204

    Article  PubMed  Google Scholar 

  14. Dahiya A, Sebastian A, Thomas A, George R, Thomas V, Peedicayil A (2021) Endometriosis and malignancy: the intriguing relationship. Int J Gynecol Obstet 155(1):72–8

    Article  CAS  Google Scholar 

  15. Moro F, Leombroni M, Testa AC (2019) Ultrasound imaging in endometriosis. Obstet Gynecol Clin North Am 46(4):643–59

    Article  PubMed  Google Scholar 

  16. Timmerman D, Ameye L, Fischerova D et al (2010) Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group. BMJ 341:c6839

    Article  PubMed  PubMed Central  Google Scholar 

  17. Testa AC, Timmerman D, Van Holsbeke C et al (2011) Ovarian cancer arising in endometrioid cysts: ultrasound findings. Ultrasound Obstet Gynecol 38(1):99–106

    Article  CAS  PubMed  Google Scholar 

  18. Forstner R, Thomassin-Naggara I, Cunha TM et al (2017) ESUR recommendations for MR imaging of the sonographically indeterminate adnexal mass: an update. Eur Radiol 27(6):2248–57

    Article  PubMed  Google Scholar 

  19. Li M, Tan J, Zhang Y et al (2021) Assessing CT imaging features combined with CEA and CA125 levels to identify endometriosis-associated ovarian cancer. Abdom Radiol (NY) 46(6):2367–75

    Article  PubMed  Google Scholar 

  20. Bazot M, Bharwani N, Huchon C et al (2017) European Society of Urogenital Radiology (ESUR) guidelines: MR imaging of pelvic endometriosis. Eur Radiol 27(7):2765–75

    Article  CAS  PubMed  Google Scholar 

  21. Thomassin-Naggara I, Poncelet E, Jalaguier-Coudray A et al (2020) Ovarian-Adnexal Reporting Data System Magnetic Resonance Imaging (O-RADS MRI) Score for risk stratification of sonographically indeterminate adnexal masses. JAMA Netw Open 3(1):e1919896

    Article  PubMed  PubMed Central  Google Scholar 

  22. Tanaka YO, Yoshizako T, Nishida M, Yamaguchi M, Sugimura K, Itai Y (2000) Ovarian carcinoma in patients with endometriosis. AJR Am J Roentgenol 175(5):1423–30

    Article  CAS  PubMed  Google Scholar 

  23. Mori T, Kato H, Kawaguchi M et al (2022) A comparative analysis of MRI findings in endometrial cancer: differentiation between endometrioid adenocarcinoma, serous carcinoma, and clear cell carcinoma. Eur Radiol 32(6):4128–36

    Article  CAS  PubMed  Google Scholar 

  24. Morioka S, Kawaguchi R, Yamada Y, Iwai K, Yoshimoto C, Kobayashi H (2019) Magnetic resonance imaging findings for discriminating clear cell carcinoma and endometrioid carcinoma of the ovary. J Ovarian Res 12(1):20

    Article  PubMed  PubMed Central  Google Scholar 

  25. Andres MP, Arcoverde FVL, Souza CCC, Fernandes LFC, Abrão MS, Kho RM (2020) Extrapelvic endometriosis: a systematic review. J Minim Invasive Gynecol 27(2):373–89

    Article  PubMed  Google Scholar 

  26. Horton JD, Dezee KJ, Ahnfeldt EP, Wagner M (2008) Abdominal wall endometriosis: a surgeon’s perspective and review of 445 cases. Am J Surg 196(2):207–12

    Article  PubMed  Google Scholar 

  27. Corwin MT, Gerscovich EO, Lamba R, Wilson M, McGahan JP (2014) Differentiation of ovarian endometriomas from hemorrhagic cysts at MR imaging: utility of the T2 dark spot sign. Radiology 271(1):126–32

    Article  PubMed  Google Scholar 

  28. Tanase Y, Kawaguchi R, Takahama J, Kobayashi H (2017) Factors that differentiate between endometriosis-associated ovarian cancer and benign ovarian endometriosis with mural nodules. Magn Reson Med Sci 17(3):231–7

    Article  PubMed  PubMed Central  Google Scholar 

  29. Ghafoor S, Lakhman Y, Park KJ, Petkovska I (2020) Polypoid endometriosis: a mimic of malignancy. Abdom Radiol (NY) 45(6):1776–82

    Article  PubMed  Google Scholar 

  30. Avesani G, Caliolo G, Gui B et al (2021) Pearls and potential pitfalls for correct diagnosis of ovarian cystadenofibroma in MRI: a pictorial essay. Korean J Radiol 22(11):1809–21

    Article  PubMed  PubMed Central  Google Scholar 

  31. Takeuchi M, Matsuzaki K, Harada M (2016) Computed diffusion-weighted imaging for differentiating decidualized endometrioma from ovarian cancer. Eur J Radiol 85(5):1016–9

    Article  PubMed  Google Scholar 

  32. Zulfiqar M, Koen J, Nougaret S et al (2020) Krukenberg tumors: update on imaging and clinical features. AJR Am J Roentgenol 215(4):1020–9

    Article  PubMed  Google Scholar 

  33. Testa AC, Mancari R, Di Legge A et al (2008) The ‘lead vessel’: a vascular ultrasound feature of metastasis in the ovaries. Ultrasound Obstet Gynecol 31(2):218–21

    Article  CAS  PubMed  Google Scholar 

  34. Peyrot H, Montoriol PF, Canis M (2015) Spontaneous T1-hyperintensity within an Ovarian lesion: spectrum of diagnoses. Can Assoc Radiol J 66(2):115–20

    Article  PubMed  Google Scholar 

  35. Braschi-Amirfarzan M, Keraliya AR, Krajewski KM et al (2016) Role of imaging in management of desmoid-type fibromatosis: a primer for radiologists. Radiographics 36(3):767–82

    Article  PubMed  Google Scholar 

  36. Kalaitzopoulos DR, Samartzis N, Kolovos GN et al (2021) Treatment of endometriosis: a review with comparison of 8 guidelines. BMC Womens Health 21(1):397

    Article  PubMed  PubMed Central  Google Scholar 

  37. Smith KA, Welch BT, Kurup AN et al (2022) Feasibility and safety of percutaneous image-guided cryoablation of abdominal wall endometriosis. Abdom Radiol (NY) 47(8):2669–73

    Article  PubMed  Google Scholar 

  38. National Guideline Alliance (UK) (2017) Endometriosis: diagnosis and management. National Institute for Health and Care Excellence (NICE), London

  39. Murakami K, Kotani Y, Shiro R, Takaya H, Nakai H, Matsumura N (2020) Endometriosis-associated ovarian cancer occurs early during follow-up of endometrial cysts. Int J Clin Oncol 25(1):51–8

    Article  PubMed  Google Scholar 

Download references



Author information

Authors and Affiliations



LR and PFM have equally worked on the preparation and writing of the manuscript. MK and AM worked on the description of histological aspects. LB corrected the manuscript.

All authors read and approved the final manuscript.

Corresponding author

Correspondence to Louise Radzynski.

Ethics declarations

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1: Fig. S1.

Clear cell carcinoma within an endometrioma. Histological sample with Hps x 20 (A) and Hps x 40 (B) shows a typical endometriotic cyst with a layer of regular cells on endometrial stroma (asterisk), adjacent to a clear cell carcinoma (arrow) showing malignant glands with severe cytonuclear atypia with a pathognomonic “hobnail” appearance. Fig. S2. Endometrioid carcinoma within an endometrioma. Histological image (A) showing a typical endometriotic cyst with a layer of regular cells on endometrial stroma (arrowhead in A and B), adjacent to a endometrioid carcinoma (asterisk in A and B) (Hps x 50). Image B: CD10 staining highlighting the endometrial stroma in the endometriotic cyst (Hps x 50). Fig. S3. Typical deep-pelvic endometriosis in a 29-year-old woman with infertility. Pelvic ultrasound (A) shows bilateral ovarian endometriomas (asterisk). On axial T1-weighted MRI image (B) endometriomas (asterisks) display high signal intensity, persisting after fat-suppression (C). Coronal (D) and sagittal (E) T2-weighted image show hypointense strands (dotted arrows), joining the ovaries in a "kissing-ovaries" appearance and involvement of the anterior wall of the sigmoid. Corresponding transvaginal Ultrasound scan (F) helps estimate the depth of the digestive involvement. Fig. S4. Mixed endometrioid and clear cell carcinoma in a 47-year-old woman with history of surgery for endometriosis. Sagittal (A) and axial T2-weighted images (B) showing a mixed ovarian mass (asterisk) with endocystic peripheral nodules (arrows). There is a loss of the T2-shading intensity usually found in endometriomas. Restricted diffusion regarding the solid nodules is displayed (C: high b value and D: ADC map). Axial fat-suppressed (E) and enhanced fat suppressed (F) T1-images show marked enhancement of the mural nodules, confirmed on dynamic contrast enhancement analysis (type 3 pink curve): suspicion of malignancy. Fig. S5. Clear cell carcinoma developed on underlying endometriosis with lymph nodes invasion, and peritoneal and pulmonary metastases in a 27-year-old-woman. Sagittal T2-weighted sequence (A) shows a cystic mass (asterisk) originating from the left ovary with carcinosis of the Douglas pouch and ascites (dotted arrow). Axial T2-weighted image (B) shows peripheral nodules (black arrow) within the ovarian cyst. Axial fat-suppressed T1-weighted image (C) shows a small, left ovarian endometrioma (arrowhead). Subtraction sequence following intravenous injection of gadolinium chelates (D) shows enhancement of the ovarian endometrioma (asterisk) wall (arrow). Diffusion-weighted imaging (E, high b value) reveals multiple metastatic lymph nodes and diffuse peritoneal extension (arrowheads). Complementary chest CT (F) also revealed multiple lung metastases. Fig. S6. Differential diagnosis: severe pelvic endometriosis with complex ovarian endometriomas in a 39-year-old woman. Sagittal (A), coronal (B) and axial (C) T2 images show large bilateral ovarian endometriomas (asterisks) with a “kissing-ovaries” appearance (dotted arrow in B). Heterogeneous material is seen within the right endometrioma (white arrows in B and C). On axial fat-suppressed T1 image (D), endometriomas show typical high signal intensity due to hemorrhagic content, whereas solid material is displayed within the right endometrioma (white arrows). Evaluation of intracystic material enhancement is limited on fat-suppressed enhanced T1 image alone (E), whereas subtraction sequence displays well the lack of enhancement of the solid portions within the cyst, corresponding to simple blood clots.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Radzynski, L., Boyer, L., Kossai, M. et al. Pictorial essay: MRI evaluation of endometriosis-associated neoplasms. Insights Imaging 14, 144 (2023).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI:


  • Endometriosis
  • Neoplasm
  • MRI
  • Endometrioid carcinoma
  • Clear cell carcinoma